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The classical paradigms for effective vaccines simply do
not comply with HIV. Therefore, alternative strategies
must be developed in order to produce a prophylactic
AIDS-vaccines. Whereas the correlates of sterilizing
immunity are not well understood, there is an ever-grow-
ing consensus that cross-reactive and neutralizing anti-
bodies are an essential component of the desired immune
response against HIV. A possible scheme for rational vac-
cine design could consist of three steps. Step 1 would be
to identify a potent cross-reactive neutralizing antibody
and use it as a template of sorts to backtrack and discover
its corresponding epitope. Step 2 would then be to recon-
stitute the epitope as an effective immunogen. Step 3
would be to determine the most effective means to imple-
ment the reconstituted As a first step towards this reversed
immunological approach we have developed a means to
predict the epitope corresponding to monoclonal anti-
bodies of interest. For this the antibody is used to screen
combinatorial phage display peptide libraries thus gener-
ating panels of peptides that correspond in some fashion
to the epitope of the antibody being studied. These pep-
tides, along with the atomic coordinates of the corre-
sponding antigen are then used as input data for
computational prediction of the epitope on the surface of
its antigen by means of the algorithm – "Mapitope". The
output of Mapitope is a number of epitope candidates
ranked according to their likelihood of best representing
the bona fide epitope of the mAb. The Mapitope predic-
tion of the neutralizing epitope corresponding to the b12
human monoclonal antibody will be presented. Here we
have been able to predict the main core of the epitope and
support this prediction with experimental data and addi-
tional Mapitope analyses of the competing antibodies,
m14 and b6.
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